Tokyo Tape
Sign in
← J Frontier

Quarterly report · Q3

2934.TEDINET S100QLF7
Period2022-06-01 → 2023-02-28
Filed2023-04-14
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 35
MetricValuePeriodScopeSource row
Revenue¥12.7bn2022-06-01 → 2023-02-28Cons.Net sales
Revenue¥11.9bn2021-06-01 → 2022-05-31Cons.Net sales (5-year summary)
Revenue¥7.4bn2021-06-01 → 2022-02-28Cons.Net sales
Operating income−¥690m2022-06-01 → 2023-02-28Cons.Operating income
Operating income¥575m2021-06-01 → 2022-02-28Cons.Operating income
Ordinary income−¥709m2022-06-01 → 2023-02-28Cons.Ordinary income
Ordinary income¥712m2021-06-01 → 2022-05-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥550m2021-06-01 → 2022-02-28Cons.Ordinary income
Profit before tax−¥710m2022-06-01 → 2023-02-28Cons.Income before income taxes
Profit before tax¥550m2021-06-01 → 2022-02-28Cons.Income before income taxes
Net income (owners)−¥604m2022-06-01 → 2023-02-28Cons.Profit loss attributable to owners of parent
Net income (owners)¥401m2021-06-01 → 2022-05-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥353m2021-06-01 → 2022-02-28Cons.Profit loss attributable to owners of parent
Net income−¥559m2022-06-01 → 2023-02-28Cons.Profit loss
Net income¥353m2021-06-01 → 2022-02-28Cons.Profit loss
Total assets¥7.8bnat 2023-02-28Cons.Assets
Total assets¥6.1bnat 2022-05-31Cons.Assets
Total assets¥5.5bnat 2022-02-28Cons.Total assets (5-year summary)
Total liabilities¥3.8bnat 2023-02-28Cons.Liabilities
Total liabilities¥1.9bnat 2022-05-31Cons.Liabilities
Net assets / equity¥4.0bnat 2023-02-28Cons.Net assets
Net assets / equity¥4.2bnat 2022-05-31Cons.Net assets
Net assets / equity¥4.1bnat 2022-02-28Cons.Net assets (5-year summary)
Cash and deposits¥2.4bnat 2023-02-28Cons.Cash and deposits
Cash and deposits¥3.0bnat 2022-05-31Cons.Cash and deposits
EPS (basic)¥-131.072022-06-01 → 2023-02-28Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥-54.372022-12-01 → 2023-02-28dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥90.642021-06-01 → 2022-05-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥80.62021-06-01 → 2022-02-28Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥43.282021-12-01 → 2022-02-28dCons.Basic earnings loss per share (5-year summary)
EPS (diluted)¥86.682021-06-01 → 2022-05-31Cons.Diluted earnings per share (5-year summary)
EPS (diluted)¥76.332021-06-01 → 2022-02-28Cons.Diluted earnings per share (5-year summary)
Equity ratio48.3%at 2023-02-28Cons.Equity to asset ratio (5-year summary)
Equity ratio67.8%at 2022-05-31Cons.Equity to asset ratio (5-year summary)
Equity ratio73.5%at 2022-02-28Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 35
SegmentItemPeriodValue
Reconciling Itemsreconcilingrevenue2022-06-01 → 2023-02-28−¥139m
Reconciling Itemsreconcilingrevenue intersegment2022-06-01 → 2023-02-28−¥139m
Reconciling Itemsreconcilingsegment profit2022-06-01 → 2023-02-28−¥385m
jpcrp040300-q3r_E33800-000Healthcare Marketing Businessreportable segmentrevenue2022-06-01 → 2023-02-28¥4.0bn
jpcrp040300-q3r_E33800-000Healthcare Marketing Businessreportable segmentrevenue external2022-06-01 → 2023-02-28¥3.9bn
jpcrp040300-q3r_E33800-000Healthcare Marketing Businessreportable segmentrevenue intersegment2022-06-01 → 2023-02-28¥139m
jpcrp040300-q3r_E33800-000Healthcare Marketing Businessreportable segmentsegment profit2022-06-01 → 2023-02-28¥19m
jpcrp040300-q3r_E33800-000Healthcare Sales Businessreportable segmentrevenue2022-06-01 → 2023-02-28¥3.0bn
jpcrp040300-q3r_E33800-000Healthcare Sales Businessreportable segmentrevenue external2022-06-01 → 2023-02-28¥3.0bn
jpcrp040300-q3r_E33800-000Healthcare Sales Businessreportable segmentsegment profit2022-06-01 → 2023-02-28¥252m
jpcrp040300-q3r_E33800-000Medical Care Sales Businessreportable segmentrevenue2022-06-01 → 2023-02-28¥5.8bn
jpcrp040300-q3r_E33800-000Medical Care Sales Businessreportable segmentrevenue external2022-06-01 → 2023-02-28¥5.8bn
jpcrp040300-q3r_E33800-000Medical Care Sales Businessreportable segmentrevenue intersegment2022-06-01 → 2023-02-28¥458,000
jpcrp040300-q3r_E33800-000Medical Care Sales Businessreportable segmentsegment profit2022-06-01 → 2023-02-28−¥576m
Total Of Reportable Segments And Otherssegment totalrevenue2022-06-01 → 2023-02-28¥12.9bn
Total Of Reportable Segments And Otherssegment totalrevenue external2022-06-01 → 2023-02-28¥12.7bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2022-06-01 → 2023-02-28¥139m
Total Of Reportable Segments And Otherssegment totalsegment profit2022-06-01 → 2023-02-28−¥305m
Reconciling Itemsreconcilingrevenue2021-06-01 → 2022-02-28−¥27m
Reconciling Itemsreconcilingrevenue intersegment2021-06-01 → 2022-02-28−¥27m
Reconciling Itemsreconcilingsegment profit2021-06-01 → 2022-02-28−¥270m
jpcrp040300-q3r_E33800-000Healthcare Marketing Businessreportable segmentrevenue2021-06-01 → 2022-02-28¥2.0bn
jpcrp040300-q3r_E33800-000Healthcare Marketing Businessreportable segmentrevenue external2021-06-01 → 2022-02-28¥2.0bn
jpcrp040300-q3r_E33800-000Healthcare Marketing Businessreportable segmentrevenue intersegment2021-06-01 → 2022-02-28¥27m
jpcrp040300-q3r_E33800-000Healthcare Marketing Businessreportable segmentsegment profit2021-06-01 → 2022-02-28¥45m
jpcrp040300-q3r_E33800-000Healthcare Sales Businessreportable segmentrevenue2021-06-01 → 2022-02-28¥2.6bn
jpcrp040300-q3r_E33800-000Healthcare Sales Businessreportable segmentrevenue external2021-06-01 → 2022-02-28¥2.6bn
jpcrp040300-q3r_E33800-000Healthcare Sales Businessreportable segmentsegment profit2021-06-01 → 2022-02-28¥666m
jpcrp040300-q3r_E33800-000Medical Care Sales Businessreportable segmentrevenue2021-06-01 → 2022-02-28¥2.9bn
jpcrp040300-q3r_E33800-000Medical Care Sales Businessreportable segmentrevenue external2021-06-01 → 2022-02-28¥2.9bn
jpcrp040300-q3r_E33800-000Medical Care Sales Businessreportable segmentsegment profit2021-06-01 → 2022-02-28¥134m
Total Of Reportable Segments And Otherssegment totalrevenue2021-06-01 → 2022-02-28¥7.5bn
Total Of Reportable Segments And Otherssegment totalrevenue external2021-06-01 → 2022-02-28¥7.4bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2021-06-01 → 2022-02-28¥27m
Total Of Reportable Segments And Otherssegment totalsegment profit2021-06-01 → 2022-02-28¥845m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 342
ItemContextValueUnit
Income taxes payablePrior1YearInstant188959000JPY
Income taxes payableCurrentQuarterInstant48370000JPY
Accrued consumption taxesPrior1YearInstant64771000JPY
Accrued consumption taxesCurrentQuarterInstant34419000JPY
Advances receivedPrior1YearInstant80956000JPY
Advances receivedCurrentQuarterInstant37277000JPY
Provision for bonusesPrior1YearInstant7855000JPY
Provision for bonusesCurrentQuarterInstant12839000JPY
Provision for point card certificates clPrior1YearInstant－JPY
Provision for point card certificates clCurrentQuarterInstant29663000JPY
Other clPrior1YearInstant20839000JPY
Other clCurrentQuarterInstant54107000JPY
Current liabilitiesPrior1YearInstant1443695000JPY
Current liabilitiesCurrentQuarterInstant2434396000JPY
Bonds payablePrior1YearInstant－JPY
Bonds payableCurrentQuarterInstant50000000JPY
Long term loans payablePrior1YearInstant446069000JPY
Long term loans payableCurrentQuarterInstant1223837000JPY
Other nclPrior1YearInstant45995000JPY
Other nclCurrentQuarterInstant77354000JPY
Noncurrent liabilitiesPrior1YearInstant492064000JPY
Noncurrent liabilitiesCurrentQuarterInstant1351191000JPY
LiabilitiesPrior1YearInstant1935760000JPY
LiabilitiesCurrentQuarterInstant3785588000JPY
Capital stockPrior1YearInstant1486978000JPY
Capital stockCurrentQuarterInstant165462000JPY
Capital surplusPrior1YearInstant1469978000JPY
Capital surplusCurrentQuarterInstant3022845000JPY
Retained earningsPrior1YearInstant1630954000JPY
Retained earningsCurrentQuarterInstant1027323000JPY
Treasury stockPrior1YearInstant-452200000JPY
Treasury stockCurrentQuarterInstant-452358000JPY
Shareholders equityPrior1YearInstant4135711000JPY
Shareholders equityCurrentQuarterInstant3763272000JPY
Subscription rights to sharesPrior1YearInstant904000JPY
Subscription rights to sharesCurrentQuarterInstant10125000JPY
Non controlling interestsPrior1YearInstant26918000JPY
Non controlling interestsCurrentQuarterInstant227064000JPY
Net assetsPrior1YearInstant4163534000JPY
Net assetsCurrentQuarterInstant4000462000JPY
Liabilities and net assetsPrior1YearInstant6099295000JPY
Liabilities and net assetsCurrentQuarterInstant7786050000JPY
Net salesPrior1YTDDuration7448815000JPY
Net salesCurrentYTDDuration12720969000JPY
Cost of salesPrior1YTDDuration3222409000JPY
Cost of salesCurrentYTDDuration7608641000JPY
Gross profitPrior1YTDDuration4226405000JPY
Gross profitCurrentYTDDuration5112327000JPY
Selling general and administrative expensesPrior1YTDDuration3650929000JPY
Selling general and administrative expensesCurrentYTDDuration5802751000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2022-05-31pass rounding
balance sheet identityconsolidated 2023-02-28pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2022-05-31pass
statement vs summary · net assetsconsolidated 2023-02-28pass
statement vs summary · net income attributable to parentconsolidated 2021-06-01/2022-02-28pass
statement vs summary · net income attributable to parentconsolidated 2022-06-01/2023-02-28pass
statement vs summary · revenueconsolidated 2021-06-01/2022-02-28pass
statement vs summary · revenueconsolidated 2022-06-01/2023-02-28pass
statement vs summary · total assetsconsolidated 2022-05-31pass
statement vs summary · total assetsconsolidated 2023-02-28pass